1. Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer

   • Andrew X. Zhu
   • Jeffrey W. Clark
   • Matthew H. Kulke

   Original Article 20 June 2006 Pages: 285 - 293

   

2. Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

   • W. Yeo
   • M. Boyer
   • A. T. C. Chan

   Original Article 17 June 2006 Pages: 295 - 300

3. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin

   • Goli Samimi
   • Shuichi Kishimoto
   • Stephen B. Howell

   Original Article 13 June 2006 Pages: 301 - 312

   

4. A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer

   • Hei-Cheul Jeung
   • Sun Young Rha
   • Hyun Cheol Chung

   Original Article 13 June 2006 Pages: 313 - 320

   

5. Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin^TM) for preventing delayed diarrhea

   • Muneaki Hidaka
   • Keishi Yamasaki
   • Kazuhiko Arimori

   Original Article 13 June 2006 Pages: 321 - 328

   

6. A novel isocoumarin derivative induces mitotic phase arrest and apoptosis of human multiple myeloma cells

   • Takeshi Kawano
   • Naoki Agata
   • Donald Kufe

   Original Article 08 July 2006 Pages: 329 - 335

   

7. Irinotecan changes gene expression in the small intestine of the rat with breast cancer

   • Joanne M. Bowen
   • Rachel J. Gibson
   • Dorothy M. K. Keefe

   Original Article 24 June 2006 Pages: 337 - 348

   

8. cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib

   • Michele Bianchini
   • Giovanni Martinelli
   • Irene Larripa

   Original Article 29 September 2006 Pages: 349 - 360

   

9. Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

   • M. Reni
   • S. Cereda
   • V. Di Carlo

   Original Article 29 June 2006 Pages: 361 - 367

   

10. Cisplatin’s tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng

    • Han H. Aung
    • Sangeeta R. Mehendale
    • Chun-Su Yuan

    Original Article 24 June 2006 Pages: 369 - 374

    

11. Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model

    • Enrico P. Spugnini
    • Alfonso Baldi
    • Alessandro Porrello

    Original Article 29 June 2006 Pages: 375 - 381

    

12. Reproductive toxicity evaluation of a new camptothecin anticancer agent, CKD-602, in pregnant/lactating female rats and their offspring

    • Moon-Koo Chung
    • Choong-Yong Kim
    • Jong-Choon Kim

    Original Article 01 August 2006 Pages: 383 - 395

    

13. MZ3 induces apoptosis in human leukemia cells

    • Liang Fang
    • Qiaojun He
    • Bo Yang

    Original Article 10 August 2006 Pages: 397 - 405

    

14. Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients

    • Walter J. Loos
    • Ronald de Wit
    • Jaap Verweij

    Original Article 19 October 2006 Pages: 407 - 412

    

15. TEXAS (Taxotere® EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC

    • K. Malinovszky
    • S. Johnston
    • R. Leonard

    Clinical Trial Report 29 September 2006 Pages: 413 - 418